Bangladesh Pharmas Raise 1,200 Drug Prices Over Past Few Months
This article was originally published in PharmAsia News
Bangladesh drug makers took advantage of a regulatory vacuum to increase the retail prices of more than 1,200 drugs considered non-essential, some by 100%, over the past several months.
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.